These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3798092)

  • 1. Recombinant DNA: international guidelines.
    Miller HI; Young FE
    Science; 1987 Jan; 235(4784):14. PubMed ID: 3798092
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of biosafety guidelines. Biosafety Task Force, Parenteral Drug Association.
    J Parenter Sci Technol; 1989; 43(6):252-8. PubMed ID: 2600729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems of safety in biotechnology. Products of genetic engineering and regulation of work with them].
    Vorob'ev AA; Chugasova VA; Korovkin VI
    Mol Gen Mikrobiol Virusol; 1987 Sep; (9):3-10. PubMed ID: 3323899
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for research involving recombinant DNA molecules.
    Fed Regist; 1982 Aug; 47(167):38048-68. PubMed ID: 10261475
    [No Abstract]   [Full Text] [Related]  

  • 5. USDA research rules killed; NIH panel to rewrite standards.
    Crawford M
    Science; 1986 Nov; 234(4777):668. PubMed ID: 3775360
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant DNA research; proposed actions under guidelines--National Institutes of Health.
    Fed Regist; 1979 Nov; 44(232 Pt 2):69234-51. PubMed ID: 10244499
    [No Abstract]   [Full Text] [Related]  

  • 7. National Institutes of Health: proposed guidelines for research involving recombinant DNA molecules.
    Fed Regist; 1979 Nov; 44(232 Pt 2):69210-34. PubMed ID: 10244498
    [No Abstract]   [Full Text] [Related]  

  • 8. Clear-cut biotechnology regulations are a must.
    Jefferson EG
    Med Mark Media; 1985 Jul; 20(7):28-9, 32-3. PubMed ID: 10272849
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant DNA research; actions under guidelines--NIH. Notice of actions under NIH guidelines for research.
    Fed Regist; 1982 Aug; 47(167):38040-6. PubMed ID: 10261474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant organisms pose no special hazard.
    Sun M
    Science; 1987 Aug; 237(4817):840. PubMed ID: 3616611
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of the National Institutes of Health Guidelines for Recombinant DNA Research.
    Talbot B
    Public Health Rep; 1983; 98(4):361-8. PubMed ID: 6611823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting of the Large-Scale Review Working Group of the Recombinant DNA Advisory Committee.
    Recomb DNA Tech Bull; 1984 Jun; 7(2):68-74. PubMed ID: 6473825
    [No Abstract]   [Full Text] [Related]  

  • 13. OSHA regulation of industrial applications of recombinant DNA technology.
    Korwek EL
    Recomb DNA Tech Bull; 1982 Mar; 5(1):19-29. PubMed ID: 7071378
    [No Abstract]   [Full Text] [Related]  

  • 14. Meeting of the large-scale review working group of the Recombinant DNA Advisory Committee.
    Recomb DNA Tech Bull; 1982 Mar; 5(1):29-33. PubMed ID: 7071379
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiments for which containment has been lowered under section III-0-2 of the guidelines.
    Recomb DNA Tech Bull; 1982 Mar; 5(1):48. PubMed ID: 6280252
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on the IBC chairperson's meeting.
    Milewski E
    Recomb DNA Tech Bull; 1981 Apr; 4(1):26-7. PubMed ID: 7196060
    [No Abstract]   [Full Text] [Related]  

  • 17. Statement of Assistent Director, Biological, Behavioral and Social Sciences, National Science Foundation before the Subcommittee on Science, Research, and Technology, U.S. House of Representatives, July 23, 1986.
    Kingsbury DT
    Recomb DNA Tech Bull; 1986 Sep; 9(3):139-50. PubMed ID: 3786828
    [No Abstract]   [Full Text] [Related]  

  • 18. Activities pertinent to NIH's role in overseeing recombinant DNA activities.
    Milewski E
    Recomb DNA Tech Bull; 1984 Jun; 7(2):60-4. PubMed ID: 6473823
    [No Abstract]   [Full Text] [Related]  

  • 19. Testimony before the Subcommittee on Natural Resources, Agriculture Research and Environment, and the Subcommittee on Science, Research and Technology of the Committee on Science and Technology, June 23, 1986.
    Mellon MG
    Recomb DNA Tech Bull; 1986 Sep; 9(3):162-70. PubMed ID: 3466240
    [No Abstract]   [Full Text] [Related]  

  • 20. NIOSH perspective on commercial recombinant DNA/biotechnology development.
    Pauker S
    Recomb DNA Tech Bull; 1981 Jul; 4(2):61-4. PubMed ID: 7255759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.